84 results
8-K
SCTL
Societal CDMO Inc
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
designed to place financial responsibility for the obligations and liabilities allocated to Baudax under the Separation Agreement with Baudax … and financial responsibility for the obligations and liabilities allocated to Recro under the Separation Agreement with Recro. Recro and Baudax each agreed
8-K
EX-10.2
SCTL
Societal CDMO Inc
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
by the Party requesting reimbursement or its Affiliates that are made pursuant to this Agreement, the responsibility of the other Party or any of its … , effective as of the Benefits Commencement Date, from the Recro FSAs to the corresponding Baudax FSAs. The Baudax FSAs shall assume responsibility
8-K
EX-99.1
SCTL
Societal CDMO Inc
13 Mar 14
Recro Pharma Announces New Board Members
12:00am
at Pfizer, beginning as a Medical Director in the Diabetes Clinical Research team and then assuming positions of increasing responsibility. Prior
8-K/A
EX-99.1
lywykps
10 Sep 21
Independent Auditors’ Report
4:19pm
SC TO-T
EX-99
8i3o4ws
11 Mar 24
Third party tender offer statement
4:05pm
S-1/A
EX-10.3
yw36fbmk
29 Nov 13
IPO registration (amended)
12:00am
S-1/A
EX-10.4
g2ej4g ce
29 Nov 13
IPO registration (amended)
12:00am
8-K
EX-10.4
5zd0chnyz6yq8
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
z4kds4lxss8u1 wg
13 Mar 14
Recro Pharma Announces New Board Members
12:00am
424B5
6841aegye0hqyyf2bbk
12 Dec 22
Prospectus supplement for primary offering
7:16am
S-1/A
EX-10.1
c6hvyooz
29 Nov 13
IPO registration (amended)
12:00am
424B5
n9g6wzz7vy5f8
12 Dec 22
Prospectus supplement for primary offering
7:12am
424B5
t7w5 jj5xr8xv
13 Dec 22
Prospectus supplement for primary offering
5:29pm
424B5
6dpts6re 3r93x6a
13 Dec 22
Prospectus supplement for primary offering
5:26pm